Discover Hope with Pluvicto at Regional One Health: A Targeted Treatment for Advanced Prostate Cancer
Groundbreaking radioligand therapy for PSMA+ metastatic castration-resistant prostate cancer.
Learn if Pluvicto at Regional One Health is Right for You
Our experienced team is committed to delivering comprehensive and personalized care to our patients. We are excited to offer an innovative targeted therapy for stage-4 metastatic prostate cancer: Pluvicto.
If you have PSMA-positive metastatic castration-resistant prostate cancer (PSMA+ mCRPC) and have tried other treatments, Pluvicto treatment at Regional One Health might be right for you.
“Pluvicto isn’t a cure, but it’s an excellent option to control the cancer, reduce pain, and give the patient more time,” Dr. Bilawal Ahmed said. “It has shown to improve both life expectancy and symptoms. Patients feel better, so their quality of life is improved.”
How Does Pluvicto Work?
- Pluvicto is a radiopharmaceutical used to treat adults with PSMA-positive mCRPC.
- Pluvicto is not chemotherapy. Pluvicto targets a biomarker called PSMA, which is present on many prostate cancer cells and also some healthy cells.
- Think of it in 3 steps:
- ATTACH: Pluvicto attaches to PSMA proteins on the outside of a cell.
- ABSORB: Then Pluvicto is absorbed into the cell.
- ATTACK: From inside the cell, Pluvicto attacks. It releases radiation into the PSMA+ cell, damaging or destroying it with limited damage to surrounding cells.
- Damage to healthy tissue is minimized.
- ATTACH: Pluvicto attaches to PSMA proteins on the outside of a cell.
- Pluvicto isn’t a cure but can help some men live longer and slow tumor growth.
Will Pluvicto Work for You?
- Appointments for Pluvicto treatment are by referral only.
- Before starting treatment at Regional One Health, you will meet with a nuclear medicine doctor.
- Our team will review your medical history and blood tests, and scans of your body will be taken.
- These steps will help our doctors determine if Pluvicto is the right treatment for you.
Why Choose Regional One Health for Your Pluvicto Therapy?
- Comprehensive Cancer Care – From diagnosis to survivorship, we provide personalized treatment plans, including surgery, chemotherapy, radiation, and innovative therapies.
- Expert Oncology Team – Our specialists are leaders in cancer treatment, combining advanced medical knowledge with compassionate, patient-centered care.
- Cutting-Edge Treatments & Research – Through our partnership with UT Health Science Center, we offer access to the latest clinical trials and groundbreaking therapies.
- Whole-Person Approach – We go beyond treatment with integrated support services, including nutrition counseling, pain management, and emotional wellness programs.
- Seamless, Coordinated Care – Our multidisciplinary team ensures patients receive streamlined, expert care in one location, reducing stress and improving outcomes.
Important Safety Information:
- Use of Pluvicto involves exposure to radioactivity.
- Long-term, accruing radiation exposure is associated with an increased risk for cancer. REMOVE?
- You could have side effects after treatment, such as fatigue, nausea, dry mouth, temporary dip in blood cell counts, loss of appetite, or changes in bowel movements
- Your care team will monitor your blood cell counts closely and changes are usually temporary.
Pluvicto and prostate cancer
Breaking down the power of targeted radioligand therapy
Learn More and Connect with Our Pluvicto Team
Appointments by referral only. Please ask your oncologist if Pluvicto at Regional One Health might be a suitable treatment option for you.
For more information call us at:
Regional One Health is a leading healthcare provider in the region. We are one of the first hospitals in the region to offer this radioactive drug. Our team includes experienced specialists in nuclear medicine and oncology.